The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
The cellular response to p53: the decision between life and death
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Self-citationMolecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,419
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“A major mechanism by which Mdm2 regulates p53 is by promoting it for degradation by the ubiquitin-proteasome system (Haupt et al., 1997; Kubbutat et al., 1997).”
BackgroundMethodRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 2×
“Since mdm2 is a direct target of p53, a negative autoregulatory feedback loop exists between these two proteins (reviewed in Freedman and Levine, 1999; Kubbutat and Vousden, 1998; Lozano and Montes de Oca Luna, 1998).”
BackgroundPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 2×
“Uncontrolled high levels of p53 in embryos lacking Mdm2 expression are detrimental to the developing embryo (Jones et al., 1995).”
BackgroundIs a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1×
“Indeed, ®broblasts de®cient in p21 are impaired in IR-induced growth arrest (Brugarolas et al., 1995; Deng et al., 1995), and p21-de®cient normal ®broblasts and tumor cells are more sensitive to p53-induced apoptosis (Gorospe et al., 1997; Polyak et al., 1996).”
BackgroundRetinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204 · cited 5×
“…of p53 at the N-terminus enhances its binding to the transcriptional co-activator p300 (Lambert et al., 1998), which acetylates p53 on Lys 382 (Sakaguchi et al., 1998). p53 is also acetylated on Lys 320 within its nuclear localization sequence by PCAF, another histone transacetylase…”
BackgroundInfluentialStott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D.-D., Zhou, J.-Y., Muschel, R., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-141 · Cited by 1,083
A role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046
Friesen, C., Herr, I., Krammer, P. H., & Debatin, K.-M. (1996) · Nature Medicine · doi:10.1038/nm0596-574 · Cited by 974
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
Narita, M., Shimizu, S., Ito, T., Chittenden, T., Lutz, R. J., Matsuda, H., & Tsujimoto, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14681 · Cited by 933
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes
Caelles, C., Helmberg, A., & Karin, M. (1994) · Nature · doi:10.1038/370220a0 · Cited by 843
p53 and E2F-1 cooperate to mediate apoptosis.
Wu, X., & Levine, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3602 · Cited by 839
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
Cell Surface Trafficking of Fas: A Rapid Mechanism of p53-Mediated Apoptosis
Bennett, M., Macdonald, K., Chan, S.-W., Luzio, J. P., Simari, R., & Weissberg, P. (1998) · Science · doi:10.1126/science.282.5387.290 · Cited by 754
Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119174 · Cited by 748
Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W.-W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 734
Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724
Tumor surveillance via the ARF–p53 pathway
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 717
Recruitment of p300/CBP in p53-Dependent Signal Pathways
Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 669
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcón, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660
Bax suppresses tumorigenesis and stimulates apoptosis in vivo
Yin, C., Knudson, C. M., Korsmeyer, S. J., & Dyke, T. V. (1997) · Nature · doi:10.1038/385637a0 · Cited by 654
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648
GADD45 induction of a G 2 /M cell cycle checkpoint
Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O’Connor, P. M., Fornace, A. J., & Harris, C. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3706 · Cited by 634
Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T., & Levine, A. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.554 · Cited by 610
E1A signaling to p53 involves the p19ARFtumor suppressor
de Stanchina, E., McCurrach, M. E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A. V., Prives, C., Roussel, M. F., Sherr, C. J., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.15.2434 · Cited by 609
Reactive oxygen species are downstream mediators of p53-dependent apoptosis.
Johnson, T. M., Yu, Z. X., Ferrans, V. J., Lowenstein, R. A., & Finkel, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11848 · Cited by 596
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
Asada, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1223 · Cited by 586
Control of cell cycle progression by c-Jun is p53 dependent
Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P., & Wagner, E. F. (1999) · Genes & Development · doi:10.1101/gad.13.5.607 · Cited by 574
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
Self-citationMEKK1/JNK signaling stabilizes and activates p53
Fuchs, S. Y., Adler, V., Pincus, M. R., & Ronai, Z. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10541 · Cited by 524
Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6
Freedman, D. A., & Levine, A. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7288 · Cited by 518
BRCA1 physically associates with p53 and stimulates its transcriptional activity
Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., Weber, B. L., & El-Deiry, W. S. (1998) · Oncogene · doi:10.1038/sj.onc.1201932 · Cited by 492
ATM associates with and phosphorylates p53: mapping the region of interaction
Khanna., K. K., Keating, K. E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., Gabrielli, B., Chan, D., Lees-Miller, S. P., et al. (1998) · Nature Genetics · doi:10.1038/3882 · Cited by 486
Identification of redox/repair protein Ref-1 as a potent activator of p53.
Jayaraman, L., Murthy, K. G., Zhu, C., Curran, T., Xanthoudakis, S., & Prives, C. (1997) · Genes & Development · doi:10.1101/gad.11.5.558 · Cited by 481
Identification of a novel p53 functional domain that is necessary for efficient growth suppression
Walker, K. K., & Levine, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15335 · Cited by 471
ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
Waterman, M. J. F., Stavridi, E. S., Waterman, J. L. F., & Halazonetis, T. D. (1998) · Nature Genetics · doi:10.1038/542 · Cited by 460
Genetic determinants of p53-induced apoptosis and growth arrest.
Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., & Vogelstein, B. (1996) · Genes & Development · doi:10.1101/gad.10.15.1945 · Cited by 459
Small peptides activate the latent sequence-specific DNA binding function of p53
Hupp, T. R., Sparks, A., & Lane, D. P. (1995) · Cell · doi:10.1016/0092-8674(95)90165-5 · Cited by 434
Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress
Amundson, S. A., Myers, T. G., & Fornace, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202576 · Cited by 424
Phosphorylation of p53 Serine 15 Increases Interaction with CBP
Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R., & Brady, J. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33048 · Cited by 423
p300/MDM2 complexes participate in MDM2-mediated p53 degradation
Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80140-9 · Cited by 414 · cited 1×
“…accumulation and activation of p53, but has no e ect on the basal level of p53 in untreated cells (Yuan et al., 1999). p300 interacts with p53 and Mdm2 (Grossman et al., 1998; Yuan et al., 1999), but the signi®cance of these interactions in the regulation of p53 degradation is still unclear.”
BackgroundCell-cycle arrest versus cell death in cancer therapy
Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., & Williams, J. (1997) · Nature Medicine · doi:10.1038/nm0997-1034 · Cited by 389
Huang, L. C., Clarkin, K. C., & Wahl, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4827 · Cited by 384
Bcl-2 blocks p53-dependent apoptosis.
Chiou, S. K., Rao, L., & White, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2556 · Cited by 376
Requirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced Apoptosis
Hueber, A.-O., Zörnig, M., Lyon, D., Suda, T., Nagata, S., & Evan, G. I. (1997) · Science · doi:10.1126/science.278.5341.1305 · Cited by 370
McCurrach, M. E., Connor, T. M. F., Knudson, C. M., Korsmeyer, S. J., & Lowe, S. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2345 · Cited by 369
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
Unger, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1805 · Cited by 367
Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
Böttger, A., Böttger, V., Sparks, A., Liu, W.-L., Howard, S. F., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00374-5 · Cited by 363
Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
Tao, W., & Levine, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3077 · Cited by 355
Robertson, K. D., & Jones, P. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6457 · Cited by 352
Jayaraman, L., & Prives, C. (1995) · Cell · doi:10.1016/s0092-8674(05)80007-8 · Cited by 345
JNK targets p53 ubiquitination and degradation in nonstressed cells
Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., & Ronai, Z. (1998) · Genes & Development · doi:10.1101/gad.12.17.2658 · Cited by 341
Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases
Wang, Y., & Prives, C. (1995) · Nature · doi:10.1038/376088a0 · Cited by 336
The polyproline region of p53 is required to activate apoptosis but not growth arrest
Sakamuro, D., Sabbatini, P., White, E., & Prendergast, G. C. (1997) · Oncogene · doi:10.1038/sj.onc.1201263 · Cited by 316
The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.
Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., et al. (1996) · Genes & Development · doi:10.1101/gad.10.10.1219 · Cited by 313
DNA-dependent protein kinase acts upstream of p53 in response to DNA damage
Woo, R. A., McLure, K. G., Lees-Miller, S. P., Rancourt, D. E., & Lee, P. W. K. (1998) · Nature · doi:10.1038/29343 · Cited by 309
Mechanisms of p53-mediated apoptosis
Bates, S., & Vousden, K. H. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050267 · Cited by 305
Lotem, J., & Sachs, L. (1993) · Blood · doi:10.1182/blood.v82.4.1092.1092 · Cited by 301
Shieh, S.-Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1815 · Cited by 300
p21Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells
Gorospe, M., Cirielli, C., Wang, X., Seth, P., Capogrossi, M. C., & Holbrook, N. J. (1997) · Oncogene · doi:10.1038/sj.onc.1200897 · Cited by 294
Venot, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4668 · Cited by 292
The candidate tumour suppressor p33ING1cooperates with p53 in cell growth control
Garkavtsev, I., Grigorian, I. A., Ossovskaya, V. S., Chernov, M. V., Chumakov, P. M., & Gudkov, A. V. (1998) · Nature · doi:10.1038/34675 · Cited by 290
The INK4a/ARF tumor suppressor: one gene—two products—two pathways
Chin, L., Pomerantz, J., & DePinho, R. A. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01236-5 · Cited by 288
A Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis
Friedlander, P., Haupt, Y., Prives, C., & Oren, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4961 · Cited by 278
Self-citationDifferential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function
Ludwig, R. L., Bates, S., & Vousden, K. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4952 · Cited by 275
p38 Kinase Mediates UV-induced Phosphorylation of p53 Protein at Serine 389
Huang, C., Ma, W.-Y., Maxiner, A., Sun, Y., & Dong, Z. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12229 · Cited by 275
The BRCA 2 gene product functionally interacts with p53 and RAD51
Marmorstein, L. Y., Ouchi, T., & Aaronson, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13869 · Cited by 267
RB Regulates the Stability and the Apoptotic Function of p53 via MDM2
Hsieh, J.-K., Chan, F. S. G., O’Connor, D. J., Mittnacht, S., Zhong, S., & Lu, X. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80309-3 · Cited by 255
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran, S., Englert, C., Bennett, P., Heinrich, G., & Haber, D. A. (1995) · Genes & Development · doi:10.1101/gad.9.17.2143 · Cited by 248
(1997) · PubMed · Cited by 243
Attardi, L. D., Lowe, S. W., Brugarolas, J., & Jacks, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00739.x · Cited by 238
Mdm2 association with p53 targets its ubiquitination
Fuchs, S. Y., Adler, V., Buschmann, T., Wu, X., & Ronai, Z. (1998) · Oncogene · doi:10.1038/sj.onc.1202200 · Cited by 236
Cell type-specific inhibition of p53-mediated apoptosis by mdm2.
Haupt, Y., Barak, Y., & Oren, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00504.x · Cited by 228
Self-citationInactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member
Wadhwa, R., Takano, S., Robert, M., Yoshida, A., Nomura, H., Reddel, R. R., Mitsui, Y., & Kaul, S. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29586 · Cited by 223
Wild-type p53 negatively regulates the expression of a microtubule-associated protein.
Murphy, M., Hinman, A., & Levine, A. J. (1996) · Genes & Development · doi:10.1101/gad.10.23.2971 · Cited by 221
Essential role for p53-mediated transcription in E1A-induced apoptosis.
Sabbatini, P., Lin, J., Levine, A. J., & White, E. (1995) · Genes & Development · doi:10.1101/gad.9.17.2184 · Cited by 215
Gervais, J. L. M., Seth, P., & Zhang, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19207 · Cited by 212
Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation
Kapoor, M., & Lozano, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2834 · Cited by 211
The role of p53 in tumour suppression: lessons from mouse models
Attardi, L. D., & Jacks, T. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050269 · Cited by 201
Pan, H., Yin, C., Dyson, N. J., Harlow, E., Yamasaki, L., & Van Dyke, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80273-7 · Cited by 197
Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways
Barlow, C., Brown, K. D., Deng, C.-X., Tagle, D. A., & Wynshaw-Boris, A. (1997) · Nature Genetics · doi:10.1038/ng1297-453 · Cited by 197
Sabbatini, P., Chiou, S.-K., Rao, L., & White, E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.1060 · Cited by 191
p53 is a general repressor of RNA polymerase III transcription
Cairns, C. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3112 · Cited by 190
Signal transduction pathways that regulate cell survival and cell death
Dragovich, T., Rudin, C. M., & Thompson, C. B. (1998) · Oncogene · doi:10.1038/sj.onc.1202587 · Cited by 188
Gil-Gomez, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7209 · Cited by 184
Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences.
Whitacre, C. M., Hashimoto, H., Tsai, M. L., Chatterjee, S., Berger, S. J., & Berger, N. A. (1995) · PubMed · Cited by 178
The dual role model for p53 in maintaining genomic integrity
Janus, F., Albrechtsen, N. J. W., Dornreiter, I., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050266 · Cited by 176
p21/p53, Cellular Growth Control and Genomic Integrity
El-Deiry, W. S. (1998) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-71941-7_6 · Cited by 173
p53 Is Phosphorylated by CDK7-Cyclin H in a p36MAT1-Dependent Manner
Ko, L. J., Shieh, S.-Y., Chen, X., Jayaraman, L., Tamai, K., Taya, Y., Prives, C., & Pan, Z.-Q. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7220 · Cited by 173
Israeli, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4384 · Cited by 173
Wu, L., & Levine, A. J. (1997) · Molecular Medicine · doi:10.1007/bf03401691 · Cited by 172
Lu, H., Fisher, R. P., Bailey, P., & Levine, A. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5923 · Cited by 172
Stewart, Z. A., Leach, S. D., & Pietenpol, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.205 · Cited by 168 · cited 1×
“The presence of p21 appears necessary to prevent improper reentry into S phase that would lead to polyploidy (Stewart et al., 1999).”
BackgroundDetermination of cell fate by c-Abl activation in the response to DNA damage
Kharbanda, S., Yuan, Z.-M., Weichselbaum, R., & Kufe, D. (1998) · Oncogene · doi:10.1038/sj.onc.1202571 · Cited by 168
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
Pierce, A. M., Gimenez-Conti, I. B., Schneider‐Broussard, R., Martinez, L. A., Conti, C. J., & Johnson, D. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8858 · Cited by 163
Lu, H., Taya, Y., Ikeda, M., & Levine, A. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6399 · Cited by 162
Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage
Chen, L., Agrawal, S., Zhou, W., Zhang, R., & Chen, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.195 · Cited by 159
The p53-Binding Protein 53BP2 Also Interacts with Bcl2 and Impedes Cell Cycle Progression at G 2 /M
Naumovski, L., & Cleary, M. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3884 · Cited by 158
p53 represses ribosomal gene transcription
Budde, A., & Grummt, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202402 · Cited by 157
Roperch, J.-P., Alvaro, V., Prieur, S., Tuynder, M., Nemani, M., Lethrosne, F., Piouffre, L., Gendron, M.-C., Israeli, D., Dausset, J., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-835 · Cited by 152
Covalent and noncovalent modifiers of the p53 protein
Jayaraman, L., & Prives, C. L. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050271 · Cited by 150
Keeping an old friend under control: regulation of p53 stability
Kubbutat, M. H. G., & Vousden, K. H. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01260-x · Cited by 149
Jones, D. L., & Münger, K. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2905-2912.1997 · Cited by 146
di Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A., & Baserga, R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1084 · Cited by 141
Bissonnette, N., & Hunting, D. J. (1998) · Oncogene · doi:10.1038/sj.onc.1201899 · Cited by 141
Johnson, P., Chung, S. W., & Benchimol, S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1456-1463.1993 · Cited by 140
Brady, H. J. M., Salomons, G. S., Bobeldijk, R. C., & Berns, A. J. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00463.x · Cited by 126
Leri, A., Liu, Y., Claudio, P. P., Kajstura, J., Wang, X., Wang, S., Kang, P., Malhotra, A., & Anversa, P. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65302-3 · Cited by 123
JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases
Hu, M. C. ‐., Qiu, W. R., & Wang, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1201401 · Cited by 123
Magnetization curve of a square-lattice Heisenberg antiferromagnet
Zhitomirsky, M. E., & Nikuni, T. (1998) · Physical review. B, Condensed matter · doi:10.1103/physrevb.57.5013 · Cited by 120
Functional interplay between p53 and E2F through co-activator p300
Lee, C., Sørensen, T. S., Shikama, N., & Thangue, N. B. L. (1998) · Oncogene · doi:10.1038/sj.onc.1201818 · Cited by 115
Wagener, C., Bargou, R. C., Daniel, P. T., Bommert, K., Mapara, M. Y., Royer, H. D., & D�rken, B. (1996) · International Journal of Cancer · Cited by 113
Ubiquitin, E6-AP, and Their Role in p53 Inactivation
Scheffner, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00003-5 · Cited by 111
Anti‐apoptotic activity of low levels of wild‐type p53.
Lassus, P., Ferlin, M., Piette, J., & Hibner, U. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00834.x · Cited by 108
Role for p300 in Stabilization of p53 in the Response to DNA Damage
Yuan, Z.-M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Shioya, H., Utsugisawa, Y., Yokoyama, K. K., Weichselbaum, R. R., Shi, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1883 · Cited by 107
Li, G., & Vc, H. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02305.x · Cited by 107
c-Abl Neutralizes the Inhibitory Effect of Mdm2 on p53
Sionov, R. V., Moallem, E., Berger, M., Kazaz, A., Gerlitz, O., Ben‐Neriah, Y., Oren, M., & Haupt, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8371 · Cited by 104
Self-citationHengstschläger, M., Braun, K., Soucek, T., Miloloza, A., & Hengstschläger-Ottnad, E. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(98)00022-2 · Cited by 102
Induction of Mdm2 and enhancement of cell survival by bFGF
Shaulian, E., Resnitzky, D., Shifman, O., Blandino, G., Amsterdam, A., Yayon, A., & Oren, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201453 · Cited by 102
Li, G., & Vc, H. (1998) · PubMed · Cited by 99
McKay, B. C., Ljungman, M. E., & Rainbow, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1201963 · Cited by 92
Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System
Ding, H., McGill, G. G., Rowan, S., Schmaltz, C., Shimamura, A., & Fisher, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28378 · Cited by 90
Identification of an additional negative regulatory region for p53 sequence-specific DNA binding
Müller‐Tiemann, B., Halazonetis, T. D., & Elting, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6079 · Cited by 89
Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation
Wang, X., Ohnishi, K., Takahashi, A., & Ohnishi, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202216 · Cited by 87
Bcl-2 inhibits p53 nuclear import following DNA damage
Beham, A. W., Marín, M. C., Fernandez, A., Herrmann, J. L., Brisbay, S. M., Tari, A. M., Lopez‐Berestein, G., Lozano, G., Sarkiss, M. G., & McDonnell, T. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201464 · Cited by 86
Regulation of CAK kinase activity by p53
Schneider, E., Montenarh, M., & Wagner, P. (1998) · Oncogene · doi:10.1038/sj.onc.1202504 · Cited by 85
Suppression of the p300-dependent mdm2negative-feedback loop induces the p53 apoptotic function
Thomas, A. E., & White, E. (1998) · Genes & Development · doi:10.1101/gad.12.13.1975 · Cited by 85
Ruaro, E. M., Collavin, L., Del Sal, G., Haffner, R., Oren, M., Levine, A. J., & Schneider, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4675 · Cited by 82
Flaman, J., Robert, V., Lenglet, S., Moreau, V., Iggo, R. D., & Frébourg, T. (1998) · Oncogene · doi:10.1038/sj.onc.1201889 · Cited by 81
Mechanisms of p53-Mediated Apoptosis
Ding, H., & Fisher, D. E. (1998) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v9.i1.60 · Cited by 75
Cytokines Inhibit p53-Mediated Apoptosis but Not p53-Mediated G1 Arrest
Lin, Y., & Benchimol, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6045 · Cited by 75
p53 facilitates pRb cleavage in IL‐3‐deprived cells: novel pro‐apoptotic activity of p53
Gottlieb, E., & Oren, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3587 · Cited by 73
Inhibition of p53 Transcriptional Activity by Bcl-2 Requires Its Membrane-anchoring Domain
Froesch, B. A., Aimé, C., Leber, B. F., Andrews, D. W., & Reed, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6469 · Cited by 70
Regulation of the mdm2 Oncogene by Thyroid Hormone Receptor
Qi, J.-S., Yuan, Y., Desai-Yajnik, V., & Samuels, H. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.864 · Cited by 67
Dumaz, N., Duthu, A., Ehrhart, J., Drougard, C., Appella, E., Anderson, C. W., May, P., Sarasin, A. R., & Daya–Grosjean, L. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199712)20:4<340::aid-mc3>3.0.co;2-n · Cited by 66
Liu, Y., Bohn, S. A., & Sherley, J. L. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.1.15 · Cited by 65
The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo
Reinke, V., & Lozano, G. (1997) · Oncogene · doi:10.1038/sj.onc.1201316 · Cited by 63
Blaydes, J. P., & Wynford‐Thomas, D. (1998) · Oncogene · doi:10.1038/sj.onc.1201880 · Cited by 61
Reinke, V., & Lozano, G. (1997) · Radiation Research · doi:10.2307/3579567 · Cited by 58
Arriola, E. L., Lopez, A. R., & Chresta, C. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202391 · Cited by 58
WT1—more than a transcription factor?
Englert, C. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01277-8 · Cited by 56
Discrimination of DNA Binding Sites by Mutant p53 Proteins
Thukral, S. K., Lu, Y., Blain, G. C., Harvey, T. S., & Jacobsen, V. L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.5196 · Cited by 48
The in Vitro Phosphorylation of P53 by Calcium‐Dependent Protein Kinase C
Delphi, C., Huang, K., Scotto, C., Chapel, A., Vinçon, M., CHAMBAZ, E. M., Garin, J., & Baudier, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00684.x · Cited by 44
Effect of Phosphorylation on Tetramerization of the Tumor Suppressor Protein p53
Sakaguchi, K., Sakamoto, H., Xie, D., Erickson, J. W., Lewis, M. S., Anderson, C. W., & Appella, E. (1997) · Journal of Protein Chemistry · doi:10.1023/a:1026334116189 · Cited by 39
Protein kinase C isoform levels in normal and sodium dodecyl sulphate-irritated mouse skin
LI, Fiedler, & Kumar (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02306.x · Cited by 39
Choisy, C., Reisdorf, P., & Yonish-Rouach, E. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00238-0 · Cited by 38
Thyroid Hormone Receptor Is a Negative Regulator in p53-Mediated Signaling Pathways
Barrera-Hernandez, G., Zhan, Q., Wong, R. S. L., & Cheng, S.-Y. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.743 · Cited by 37
The apoptotic and transcriptional transactivation activities of p53 can be dissociated.
Bissonnette, N., Wasylyk, B., & Hunting, D. J. (1997) · PubMed · Cited by 35
Lozano, G., & Luna, R. M. D. O. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00037-1 · Cited by 30
The apoptotic and transcriptional transactivation activities of p53 can be dissociated
Bissonnette, N., & Hunting, D. J. (1997) · Biochemistry and Cell Biology · doi:10.1139/o97-058 · Cited by 30
Apoptosis by p53: mechanisms, regulation, and clinical implications
Sionov, R. V., & Haupt, Y. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00787230 · Cited by 28
Self-citationThe role of p53 as a transcription factor in the induction of apoptosis.
Yonish-Rouach, E., Choisy, C., Deguin, V., Breugnot, C., & May, E. (1996) · PubMed · Cited by 12
Cited by
Cellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,297
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
Self-citationmCSM: Predicting the effects of mutations in proteins using graph-based signatures
Pires, D. E. V., Ascher, D. B., & Blundell, T. L. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt691 · Cited by 1,066
The INK4a/ARF network in tumour suppression
Sherr, C. J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096061 · Cited by 996
Metadata
- Authors
- Sionov, R. V., & Haupt, Y.
- Venue
- Oncogene
- Published
- 1999-11-01
- Volume
- 18
- Issue
- 45
- Pages
- 6145-6157
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1985999867
- Cited by
- 601
- References
- 178
- FWCI
- 17.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.